263 related articles for article (PubMed ID: 35234272)
1. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review).
Li YS; Ren HC; Cao JH
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35234272
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm'.
Gasparello J; Marzaro G; Papi C; Gentili V; Rizzo R; Zurlo M; Scapoli C; Finotti A; Gambari R
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477130
[TBL] [Abstract][Full Text] [Related]
3. Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective.
Zurlo M; Nicoli F; Borgatti M; Finotti A; Gambari R
Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35059731
[TBL] [Abstract][Full Text] [Related]
4. Digestive system infection by SARS‑CoV‑2: Entry mechanism, clinical symptoms and expression of major receptors (Review).
Zheng L; Zhang L; Zheng Y; An J; Wen G; Jin H; Tuo B
Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36660939
[TBL] [Abstract][Full Text] [Related]
5. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
[TBL] [Abstract][Full Text] [Related]
6. An integrative look at SARS‑CoV‑2 (Review).
Ortega MA; Fraile-Martínez O; García-Montero C; García-Gallego S; Sánchez-Trujillo L; Torres-Carranza D; Álvarez-Mon MÁ; Pekarek L; García-Honduvilla N; Bujan J; Álvarez-Mon M; Asúnsolo Á; De la Torre B
Int J Mol Med; 2021 Feb; 47(2):415-434. PubMed ID: 33416095
[TBL] [Abstract][Full Text] [Related]
7. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
8. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
9. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).
Cai L; Guo X; Cao Y; Ying P; Hong L; Zhang Y; Yi G; Fu M
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576441
[TBL] [Abstract][Full Text] [Related]
10. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review).
Vivarelli S; Falzone L; Torino F; Scandurra G; Russo G; Bordonaro R; Pappalardo F; Spandidos DA; Raciti G; Libra M
Int J Oncol; 2021 Feb; 58(2):145-157. PubMed ID: 33491759
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.
Kosmaczewska A; Frydecka I
Pol Arch Intern Med; 2020 Sep; 130(9):779-788. PubMed ID: 32627515
[TBL] [Abstract][Full Text] [Related]
12. Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.
Gupta D; Sharma R; Patwardhan B; Mathur RD
J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585882
[TBL] [Abstract][Full Text] [Related]
13. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
14. Preventing the suspension of dental clinics by minimizing the risk of SARS‑CoV‑2 transmission during dental treatment.
Czajkowska S; Potempa N; Rupa-Matysek J; Surdacka A
Dent Med Probl; 2021; 58(3):397-403. PubMed ID: 34597482
[TBL] [Abstract][Full Text] [Related]
15. Contributing factors common to COVID‑19 and gastrointestinal cancer.
Kostoff RN; Briggs MB; Kanduc D; Shores DR; Kovatsi L; Drakoulis N; Porter AL; Tsatsakis A; Spandidos DA
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779496
[TBL] [Abstract][Full Text] [Related]
16. What should a cardiologist know about coronavirus disease 2019?
Sławiński G; Lewicka E
Kardiol Pol; 2020 Apr; 78(4):278-283. PubMed ID: 32336069
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic role of chest computed tomography in coronavirus disease 2019.
Jędrusik P; Gaciong Z; Sklinda K; Sierpiński R; Walecki J; Gujski M
Pol Arch Intern Med; 2020 Jun; 130(6):520-528. PubMed ID: 32385976
[TBL] [Abstract][Full Text] [Related]
18. Lessons from SARS‑CoV‑2 and its variants (Review).
Qin Z; Sun Y; Zhang J; Zhou L; Chen Y; Huang C
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35730623
[TBL] [Abstract][Full Text] [Related]
19. Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals.
Tsatsakis A; Vakonaki E; Tzatzarakis M; Flamourakis M; Nikolouzakis TK; Poulas K; Papazoglou G; Hatzidaki E; Papanikolaou NC; Drakoulis N; Iliaki E; Goulielmos GN; Kallionakis M; Lazopoulos G; Kteniadakis S; Alegkakis A; Farsalinos K; Spandidos DA
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34515322
[TBL] [Abstract][Full Text] [Related]
20. A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review).
Lempesis IG; Georgakopoulou VE; Reiter RJ; Spandidos DA
Int J Mol Med; 2024 Mar; 53(3):. PubMed ID: 38299237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
